Non-invasive scoring systems of liver fibrosis predict prognosis in the cohort with myocardial infarction

Non-invasive scoring systems of liver fibrosis predict prognosis in the cohort with myocardial infarction

Abstract Patients with liver fibrosis and type 2 diabetes mellitus (T2DM) have an increased risk of cardiovascular events. However, long-term prognosis of liver fibrosis and T2DM after acute myocardial infarction (AMI) remain to be investigated. This study compared clinical characteristics and progn...

Full description

Saved in:

Bibliographic Details
Main Authors:	Esther Wong, Yiming Chen, Gwyneth Kong, Jobelle Chia, Audrey Zhang, Anurag Mehta, Jayanth Jayabaskaran, Bryan Chong, Grace Cao, Benjamin Nah, Mark Yan-Yee Chan, Mark Muthiah, Poay-Huan Loh, Mamas A. Mamas, Nicholas WS Chew
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-07-01
Series:	Scientific Reports
Subjects:	Metabolic dysfunction-associated steatotic liver disease Non-invasive tests Fibrosis-4 index Aspartate aminotransferase to platelet ratio index Non-alcoholic fatty liver disease fibrosis score Acute coronary syndrome
Online Access:	https://doi.org/10.1038/s41598-025-12583-6
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Non-linear relationship between the hepatic steatosis index and glycemic progression: evidence from a large-scale retrospective cohort study in a Chinese population
by: Changchun Cao, et al.
Published: (2025-07-01)

Physical activity and elevated liver enzymes: A cross-sectional study from the PERSIAN Guilan cohort study
by: Heydar Ali Balou, et al.
Published: (2025-03-01)

Association of antinuclear antibody positivity with liver disease severity in pediatric metabolic dysfunction-associated steatotic liver disease
by: Hyun Jin Kim, et al.
Published: (2025-02-01)

Liver Stiffness, Not Steatosis, Predicts Mortality in MASLD Patients: An NHANES Analysis
by: Yuting Huang, et al.
Published: (2024-12-01)

Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease
by: Yuri Cho
Published: (2024-11-01)

Assessment of liver fibrosis by acoustic radiation force impulse elastography in rheumatic disease patients on long-term methotrexate treatment
by: Arindam Nandy Roy, et al.
Published: (2020-01-01)

Sequential Diagnostic Approach Using FIB-4 and ELF for Predicting Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Yeo-Wool Kang, et al.
Published: (2024-11-01)

Asymptomatic elevation of serum aminotransferase activity: stages of diagnostic search
by: Yu. A. Tereshchenko, et al.
Published: (2014-07-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease in the Korean General Population: Epidemiology, Risk Factors, and Non-Invasive Screening
by: Yong Jun Choi, et al.
Published: (2025-04-01)

Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019
by: Jacob Romano, et al.
Published: (2025-01-01)

Prevalence of steatotic liver disease and associated fibrosis in the general population: An epidemiological survey: Letter to the editor on “Epidemiology of metabolic dysfunction-associated steatotic liver disease”
by: Lin Guan, et al.
Published: (2025-04-01)

Prediction of hepatic fibrosis using the aspartate transaminase-to-platelet ratio index in children and adolescents with metabolic dysfunction-associated steatotic liver disease
by: Hye Young Jin, et al.
Published: (2024-11-01)

Morpho-functional state of the liver and changes of blood biochemical parameters in rats exposed to lead sulfide nanoparticles in the remote terms of research
by: Omelchuk S.T., et al.
Published: (2014-06-01)

Association between alcohol consumption and hepatic fibrosis in Chinese adult males with metabolic dysfunction-associated steatotic liver disease
by: Mao Li, et al.
Published: (2025-04-01)

Effects of Resveratrol on Liver Function Tests in Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: P. Ebrahimpour, et al.
Published: (2024-03-01)

Changes in liver function test levels in HIV patients undergoing highly active antiretroviral therapy (HAART). Longitudinal study in Lima, Peru
by: Jeel Moya-Salazar, et al.
Published: (2022-01-01)

Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study
by: Ziping Song, et al.
Published: (2025-04-01)

Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2024-12-01)

Association between herbicide exposure and liver enzyme levels in a middle-aged and elderly population
by: Weiya LI, et al.
Published: (2025-06-01)

Long-term exposure to air pollution and liver fibrosis in the elderly with MASLD
by: Yanqi Lan, et al.
Published: (2025-08-01)

Validation of the diagnostic accuracy of the acFibroMASH index for at-risk MASH in patients with metabolic dysfunction-associated steatotic liver disease
by: Yunfei Wu, et al.
Published: (2025-03-01)

Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7S
by: Hiroshi Ishiba, et al.
Published: (2025-01-01)

Liver fibrosis increases the risk of subclinical atherosclerosis in patients with MASLD: a cross-sectional and longitudinal study
by: Haoyu Zhang, et al.
Published: (2025-07-01)

The fibrosis-4 index and its association with carotid atherosclerosis in type 2 diabetes: a cross-sectional study in China
by: Ying Miao, et al.
Published: (2025-01-01)

Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
by: Zhifeng Gao, et al.
Published: (2025-01-01)

Association of Abnormal Serum Bilirubin and Liver enzymes in Iraqi Patients with Metabolic Syndrome (A cross-sectional study)
by: Duaa Hussein Ali, et al.
Published: (2024-12-01)

Beyond Nonalcoholic Fatty Liver Disease: The Expansive Realm of Metabolic Dysfunction-associated Steatotic Liver Disease
by: Samir Samadarshi, et al.
Published: (2025-01-01)

The prognostic value of AST-lymphocyte ratio index in liver cancer patients treated with TACE: a systematic review and single-center retrospective study
by: Yali Tian, et al.
Published: (2025-05-01)

Age serves as the silent architect of FIB-4’s precision in unveiling advanced hepatic fibrosis in MASLD with T2DM: Correspondence to letter to the editor on “Diagnostic accuracy of the fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: a systematic review and meta-analysis”
by: Ji Won Han, et al.
Published: (2025-04-01)

Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials
by: April W. Armstrong, et al.
Published: (2025-03-01)

Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States
by: Fan Zhang, et al.
Published: (2025-01-01)

Clinical characteristics of lean and non-lean non-alcoholic fatty liver disease: a cross-sectional study
by: Mengyan Xu, et al.
Published: (2025-05-01)

Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma
by: Young-Min Jee, et al.
Published: (2025-05-01)

Association of sarcopenia and physical activity on the severity of metabolic dysfunction-associated steatotic liver disease among United States adults: NHANES 2017 - 2018
by: Xiaodie Wei, et al.
Published: (2025-05-01)

Investigation of the Effect of Creatine Monohydrate Supplementation on Mmuscle Damage in Male Climbers following Climbing to an Altitude of 4000 Meter
by: Javad Ziaolhagh, et al.
Published: (2020-07-01)

CORRECTION OF MICROCIRCULATORY DISORDERS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CHRONIC HEART FAILURE PATIENTS
by: M. E. Statsenko, et al.
Published: (2016-12-01)

Artificial Intelligence and Image Analysis-Assisted Diagnosis for Fibrosis Stage of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Ultrasonography: A Pilot Study
by: Itsuki Fujii, et al.
Published: (2024-11-01)

Association of liver fibrosis‐4 index with adverse outcomes in hypertrophic cardiomyopathy patients
by: Fuad A. Abdu, et al.
Published: (2024-12-01)

The Role of Hyperemesis Gravidarum in the First-Trimester as a Predictor of Intrahepatic Cholestasis of Pregnancy
by: Ayça Kubat Küçükyurt, et al.
Published: (2024-11-01)

Essential tools for assessing advanced fibrosis in metabolic dysfunction-associated steatotic liver disease: Editorial on “Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis”
by: Won Sohn
Published: (2025-01-01)